Gimsilumab Usage And Synthesis

Uses

Gimsilumab (MORAb-022) is a human anti-GM-CSF monoclonal antibody. Gimsilumab has the potential for the research of COVID-19 and rheumatoid arthritis (RA)[1][2].

References

[1] Criner GJ, et al. Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial. Am J Respir Crit Care Med. 2022 Jun 1;205(11):1290-1299. DOI:10.1164/rccm.202108-1859OC
[2] Crotti C, et al. Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date. Drug Des Devel Ther. 2017 Jan 13;11:211-223. DOI:10.2147/DDDT.S104233

Gimsilumab(1648796-29-5)Related Product Information

• Inolimomab
• Rulonilimab
• Docaravimab
• Suptavumab
• Envafolimab
• Indatuximab Ravtansine
• Tafolecimab
• Voxalatamab
• Tosatoxumab
• Perakizumab